Omnia Ahmed | Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Omnia Ahmed | Medicine | Best Researcher Award

Dr. Omnia Ahmed, Nanotoxicology Project lab, Japan

Dr. Omnia H.M. Ahmed is a researcher in the field of nanotoxicology, currently working at the Nanotoxicology Project Lab in Japan. Her expertise lies in the study of various poisonous substances and drugs, focusing on their classification, mechanisms of action, clinical toxicity features, diagnosis, and management. She applies medical science principles to forensic toxicology and specializes in dependence-producing substances. Dr. Ahmed collaborates in laboratory experiments, addressing challenges in analytical toxicology, and investigates newly emerging hazardous materials, including carbon nanotubes.

Education:

Dr. Omnia Ahmed holds a Master of Medical Science in Forensic Medicine and Clinical Toxicology from the Faculty of Medicine, Aswan University, Egypt, which she completed in March 2019. She earned her M.B.B.CH degree with honors from the Faculty of Medicine and Surgery, Sohag University, Egypt, in November 2012, achieving an excellent cumulative grade of 85.02%.She is currently engaged in the Nanotoxicology Project Lab in Japan, focusing on research in nanotoxicology, forensic medicine, and clinical toxicology.

Professional Profiles:

Google Scholar

ORCID Profile

Professional Experience:

Nanotoxicology Project Lab, Japan (April 2013 – March 2014)

Conducted research on nanotoxicology, focusing on the impact of nanomaterials on biological systems.

Trainee Course (Full-time Employee), University Hospital, Faculty of Medicine and Surgery, Sohag University, Egypt (April 2014 – March 2015)

Completed a comprehensive training program in various medical disciplines, gaining hands-on clinical experience.

General Practitioner, Ministry of Health, Egypt (April 2015 – June 2015)

Provided primary healthcare services, diagnosing and treating a variety of medical conditions.

Physician, Internal Medicine and Clinical Toxicology Department, Edfu General Hospital, Aswan City, Egypt (July 2015 – April 2019)

Managed cases related to internal medicine and clinical toxicology, including poisoning and toxin exposure treatments.

Demonstrator & Research Associate, Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Aswan University, Egypt (April 2019 – Present)

Assisted in teaching forensic medicine and clinical toxicology to medical students.

Assistant Professor, Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Aswan University, Egypt (April 2019 – Present)

Led courses in forensic medicine, clinical toxicology, and medico-legal studies.

Researcher, Nano-Toxicology Lab Project, Experimental Pathology and Tumor Biology Department, School of Medical Science, Nagoya City University, Japan (October 2022 – Present)

Conducting advanced research on nanotoxicology, studying the effects of nanoparticles on human health.

Ph.D. Student, Nano-Toxicology Lab Project, Experimental Pathology and Tumor Biology Department, School of Medical Science, Nagoya City University, Japan (October 2022 – Present)

Pursuing doctoral research in nanotoxicology, focusing on nanoparticle interactions with biological systems.

Research Interests:

Nanotoxicology: Investigating the toxic effects of nanomaterials, particularly carbon nanotubes, on human health and the environment.

Analytical Toxicology: Developing methods for detecting and analyzing poisonous substances and drugs.

Forensic Toxicology: Applying medical sciences to legal investigations involving toxic substances.

Drug Toxicity and Dependence: Studying the mechanisms, clinical features, and management of toxic and dependence-producing substances.

Toxicokinetics and Toxicodynamics: Understanding how toxic substances interact with biological systems.

Emerging Toxicants: Assessing newly introduced hazardous substances and their potential risks.

Team-Based Laboratory Research: Conducting collaborative experiments to address challenges in toxicology.

 Awards And Honors :

Dr. Omnia Ahmed has achieved significant academic milestones, including an Excellent degree with Class Honors in M.B.B.CH from Sohag Faculty of Medicine, Sohag University in 2012, and a Very Good Degree in M.SC. Forensic Medicine and Clinical Toxicology from Aswan Faculty of Medicine, Aswan University in 2019. She is currently a recipient of the MEXT Scholarship in Japan, spanning from April 2022 to October 2026.

Top Notable Publications:

A Review of the Carcinogenic Potential of Thick Rigid and Thin Flexible Multi-Walled Carbon Nanotubes in the Lung

Authors: Omnia Hosny Mohamed Ahmed, Aya Naiki-Ito, Satoru Takahashi, William T. Alexander, et al.

Journal: Nanomaterials

Volume: 15(3), Article 168

Year: 2025

Fullerene and Fullerene Whisker are Not Carcinogenic to the Lungs and Pleura in Rat Long-Term Study After 2-Week Intra-Tracheal Intrapulmonary Administration

Authors: AN Sheema, A Naiki-Ito, A Kakehashi, OHM Ahmed, DB Alexander, et al.

Journal: Archives of Toxicology

Volume: 98(12), Pages 4143-4158

Year: 2024

Assessment of Pulmonary Toxicity and Carcinogenicity of Carbon Nano-Horns (CNH) and Carbon Nano-Brushes (CNB) Using Intra Tracheal Instillation in Rats

Authors: OHM Ahmed, DM Saleh, DB Alexander, WT Alexander, et al.

Conference: The 51st Annual Meeting of the Japanese Society of Toxicology

Year: 2024

Carcinogenicity Risk Assessment of Various Carbon Nanotubes by Intra-Tracheal Intra-Pulmonary Spray (TIPS) Dosing Followed by 2-Year Observation

Authors: H Tsuda, O Ahmed, D Saleh, W Alexander, D Alexander, T Numano, et al.

Journal: Annals of Work Exposures and Health

Volume: 67 (Supplement_1), Pages i43-i44

Year: 2023

SOC-III-01 The Toxic and Carcinogenic Potential of Three Different Sizes of Double-Walled Carbon Nanotubes in the Rat Lung After Intratracheal Instillation

Authors: DM Saleh, WT Alexander, DB Alexander, M Abdelgaied, AM El-Gazzar, OHM Ahmed, et al.

Journal: Toxicology Letters

Volume: 368, Pages S42-S43

Year: 2022

Assessment of the Toxicity and Carcinogenicity of Double-Walled Carbon Nanotubes in the Rat Lung After Intratracheal Instillation: A Two-Year Study

Authors: DM Saleh, S Luo, OHM Ahmed, DB Alexander, WT Alexander, et al.

Journal: Particle and Fibre Toxicology

Volume: 19(1), Article 30

Year: 2022

Comparative Toxicity and Carcinogenicity Pulmonary Study of Double-Walled Carbon Nanotubes (DWCNT) with Multi-Walled Carbon Nanotubes-7 (MWCNTs-7) in a Rat Model

Authors: DM Saleh, S Luo, DB Alexander, AM El-Gazzar, M Abdelgaied, OHM Ahmed, et al.

Conference: The 48th Annual Meeting of the Japanese Society of Toxicology

Poster: P-33E

Year: 2021

Comparative Carcinogenicity Study of a Thick, Straight-Type and a Thin, Tangled-Type Multi-Walled Carbon Nanotube Administered by Intra-Tracheal Instillation in the Rat

Authors: DM Saleh, WT Alexander, T Numano, OHM Ahmed, S Gunasekaran, et al.

Journal: Particle and Fibre Toxicology

Volume: 17, Pages 1-14

Citations: 38

Year: 2020

Evaluation of Poisoning Patterns in Aswan Governorate in the Period from 1st of June 2017 to 31st of December 2017 (Prospective Study)

Authors: OH Mohamed, SM George, HA Yassa

Journal: Zagazig Journal of Forensic Medicine

Volume: 17(2), Pages 84-95

Citations: 3

Year: 2019

Conclusion:

Dr. Omnia Ahmed is a strong contender for the Best Researcher Award given her expertise in nanotoxicology, research impact, and global collaborations. Strengthening her application with clear metrics of impact, leadership roles, and interdisciplinary influence would further solidify her case.

 

 

 

Xiangyu Zhong | Medicine | Best Researcher Award

Posted on by ScienceFather

Prof. Xiangyu Zhong | Medicine | Best Researcher Award

Prof. Xiangyu Zhong, The 2nd Affiliated Hospital of Harbin Medical University, China

Professor Xiangyu Zhong is a distinguished academic and chief physician at the Department of General Surgery, The 2nd Affiliated Hospital of Harbin Medical University, China. With a robust background in medicine and extensive clinical experience, his research primarily focuses on cholangiocarcinoma, Metabolic Associated Fatty Liver Disease (MAFLD), and hepatic ischemia-reperfusion injury.

Professional Profiles:

Scopus

Professional Experience:

Prof. Xiangyu Zhong is a distinguished academician with a robust educational background in medicine. He serves as a Professor and Chief Physician in the Department of General Surgery at the Second Affiliated Hospital of Harbin Medical University. With extensive clinical expertise, he has significantly contributed to medical research, particularly in the fields of cholangiocarcinoma, Metabolic Associated Fatty Liver Disease (MAFLD), and hepatic ischemia-reperfusion injury. His academic journey is complemented by 57 publications in SCI/Scopus indexed journals, with a citation index of 1172, solidifying his position as a leading researcher in his field.

Research Interests:

Prof. Zhong’s research is focused on cholangiocarcinoma, MAFLD, and hepatic ischemia-reperfusion injury. His work has substantially enhanced the understanding of these diseases, offering valuable insights into their pathogenesis and potential therapeutic approaches. With three ongoing research projects, his contributions continue to shape the future of clinical treatments and patient care in liver diseases. Although there are no consultancy or industry projects, Prof. Zhong’s research alone has garnered significant recognition, evidenced by his numerous publications and citation index. His contributions have directly impacted advancements in surgical techniques and liver disease management.

Contributions and Impact:

Prof. Zhong’s impactful research has led to significant advancements in understanding complex liver diseases such as cholangiocarcinoma, MAFLD, and hepatic ischemia-reperfusion injury. His work, which has been cited over 1,100 times, is widely recognized for providing new insights and therapeutic approaches that directly benefit patient care. The depth of his research has influenced both the scientific community and clinical practices, furthering knowledge in areas critical for the treatment of liver-related ailments. With a high citation index and numerous peer-reviewed publications, his work continues to drive innovation in liver surgery and related fields.

Publications:

Circ_0007534 Promotes Cholangiocarcinoma Stemness and Resistance to Anoikis through DDX3X-Mediated Positive Feedback Regulation of Parental Gene DDX42
Liu, S., Guan, C., Sha, X., Zhong, X., Jiang, X.
Cellular Signalling, 2024, 118, 111141

Open access

0 citations

Utilization of 3D Printing Technology in Hepatopancreatobiliary Surgery
Shi, W., Wang, J., Gao, J., Cui, Y., Zhong, X.
Journal of Zhejiang University: Science B, 2024, 25(2), pp. 123–134

Open access

1 citation

Forkhead Box O1 in Metabolic Dysfunction-Associated Fatty Liver Disease: Molecular Mechanisms and Drug Research
Sha, X., Zou, X., Liu, S., Zhong, X., Jiang, X.
Frontiers in Nutrition, 2024, 11, 1426780

Open access

1 citation

Research Progress and Applications of Epigenetic Biomarkers in Cancer
Gao, J., Shi, W., Wang, J., Zhong, X., Cui, Y.
Frontiers in Pharmacology, 2024, 15, 1308309

Open access

1 citation

Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
Gao, J., Wang, J., Guan, C., Xu, X., Zhong, X.
Journal of Cancer, 2024, 15(8), pp. 2214–2228

Open access

0 citations

Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma
Yang, C., Dong, Q., Bao, H., Xu, Y., Zhong, X.
Frontiers in Bioscience – Landmark, 2024, 29(1), 45

Open access

0 citations

Cullin-Associated and Neddylation-Dissociated Protein 1 (CAND1) Alleviates NAFLD by Reducing Ubiquitinated Degradation of ACAA2
Huang, X., Liu, X., Li, X., Yang, B., Pan, Z.
Nature Communications, 2023, 14(1), 4620

Open access

5 citations

Retraction: The Prognostic Potential and Carcinogenesis of Long Non-Coding RNA TUG1 in Human Cholangiocarcinoma
Xu, Y., Leng, K., Li, Z., Jiang, X., Cui, Y.
Oncotarget, 2023, 14, pp. 779

Retraction

0 citations

Application of Normothermic Regional Perfusion in Controlled Donation After Cardiac Death Liver Transplant Donors
Zou, X., Huang, Z., Shi, W., Cui, Y., Zhong, X.
China Journal of General Surgery, 2023, 32(7), pp. 1087–1096

Open access

1 citation

Exosomal miRNAs in the Microenvironment of Pancreatic Cancer
Zou, X., Huang, Z., Guan, C., Xu, Y., Zhong, X.
Clinica Chimica Acta, 2023, 544, 117360

Open access

1 citation

Conclusion:

Prof. Xiangyu Zhong is undoubtedly a strong contender for the Best Researcher Award due to his extensive research contributions, leadership in collaborative efforts, and impact on medical and therapeutic advancements. While there are areas where improvement could further elevate his profile, such as increasing citations and expanding clinical research involvement, his overall academic impact, innovation, and leadership make him a deserving candidate. His work not only contributes to fundamental science but also holds significant promise for improving patient care and treatment outcomes, which is at the core of the Best Researcher Award’s mission.